Dr. Jiajie Zang
Epidemiologist and StatisticianShanghai Municipal Center for Disease Control and Prevention, China
Highest Degree
Ph.D. in Epidemiology and Health Statistics from Second Military Medical University, China
Share this Profile
Shanghai Municipal Center for Disease Control and Prevention, China
Biography
Dr. Jiajie Zang is currently working as Epidemiologist and Statistician at Department of Health Related Risk Factor Identification and Control, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China. He has completed his Ph.D. in Epidemiology and Health Statistics from Second Military Medical University, China. His area of research interest focuses on Identification and control of the Health Related Risk Factors, Data management and Statistical Analysis, Diseases Surveillance, and Evidence-Based Medicine. He also completed 7 research projects funded by different agencies. He has published 13 research articles in journals as well as 3 abstracts in presentations contributed as author/co-author.
Area of Interest:
Public Health
100%
Epidemiology
62%
Statistical Analysis
90%
Statistical Methodology
75%
Evidence-Based Medicine
55%
Research Publications in Numbers
Books
0
0
Chapters
0
0
Articles
0
0
Abstracts
0
0
Selected Publications
- Zang, J., J. Xu, Xiang, C. Xu, J. He and S. Zou, 2015. Multi-level model synthesis of median survival time in Meta-analysis. Epidemiology, 26: e2-e3.
CrossRef | Direct Link | - Zang, J., C. Xiang and J. He, 2013. Synthesis of median survival time in Meta-analysis. Epidemiology, 24: 337-338.
CrossRef | Direct Link | - Zang, J., S. Wu, L. Tang, X. Xu and J. Bai et al., 2012. Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: A systematic review and meta-analysis. PloS One, Vol. 7. 10.1371/journal.pone.0030353.
CrossRef | - Yan, T., G.X. Zhang, B.l. Li, L. Han, J.J. Zang, L. Li and Z.Y. Xu, 2012. Prediction of coronary artery disease in patients undergoing operations for rheumatic aortic valve disease. Clin. Cardiol., 35: 707-711.
CrossRef | - Xie, F., J. Zang, X. Guo, F. Xu and R. Shen et al., 2012. Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: A meta-analysis. J. Cancer Res. Clin. Oncol., 138: 455-462.
CrossRef | Direct Link | - Zhou, Y.H., J.J. Zang, M.J. Wu, J.F. Xu and J. He, 2011. Allowable total error and limits for erroneous results (ATE/LER) zones for agreement measurement. J. Clin. Lab. Anal., 25: 83-89.
CrossRef | - Zhou, Y., L. Tang, S. Guo, Z. Jin and M. Wu et al., 2011. Steroids in the treatment of IgA nephropathy to the improvement of renal survival: A systematic review and meta-analysis. PLoS ONE, Vol. 6. 10.1371/journal.pone.0018788.
CrossRef | - Zhang, X., J. Zang, J. Xu, C. Bai and Y. Qin et al., 2011. Maintenance therapy with continuous or switch strategy in advanced non-small cell lung cancer: A systematic review and meta-analysis. Chest J., 140: 117-126.
Direct Link | - Zang, J.J., F. Xie, J.F. Xu, Y.Y. Qin, R.X. Shen, J.M. Yang and J. He, 2011. P16 gene hypermethylation and hepatocellular carcinoma: A systematic review and Meta-analysis. World J. Gastroenterol., 17: 3043-3048.
CrossRef | Direct Link | - Ye, X., H. Liu, C. Wu, Y. Qin and J. Zang et al., 2011. Proton pump inhibitors therapy and risk of hip fracture: A systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol., 23: 794-800.
CrossRef | Direct Link | - Wang, X., J.J. Zang, H. Wang, H. Nie and T.C. Wang et al., 2010. Pulmonary toxicity in mice exposed to low and medium doses of Water-soluble multi-walled carbon nanotubes. J. Nanosci. Nanotechnol., 10: 8516-8526.
Direct Link |